Matthias Schwab, the head of the Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology (IKP), has been accepted into the renowned Academia Europaea science academy. The award is an expression of the international perception of the scientific contributions of the IKP, says Schwab.
Prof. Dr. Matthias Schwab, the head of Dr. Margarete Fischer-Bosch-Institute for Clinical Pharmacology (IKP) at the Bosch Health Campus, has been elected as a full member of the renowned Academia Europaea science academy. He is a member of the “Clinical & Veterinary Science” section.
The Academia Europaea was founded in 1988 as a non-governmental science academy in London. Today it has around 5,000 members from the fields of physics and technology, life sciences and medicine, mathematics, humanities, social and cognitive sciences, economics and law. Among them are also 83 Nobel Prize winners.
Highest possible standards in science, research and education
The academy pursues the goals of setting the highest possible standards in science, research and education, identifying trans-European research topics and thus promoting better understanding of scientific issues among the public. Acceptance is subject exclusively to personal nomination and subsequent election by the Academy Council. “I am very happy about this European award, which expresses international perception of the scientific contributions of the Institute of Clinical Pharmacology”, says Matthias Schwab about his appointment.
Matthias Schwab has been heading the IKP since 2007. Furthermore, he is Medical Director of the Department of Clinical Pharmacology at the University Hospital in Tübingen and Chair of this subject at Tübingen University. The key area of his work is pharmacological genome research and its significance for personalised medicine. Matthias Schwab has been a full member of the Academy of Sciences and Literature Mainz already since 2012, and a member of the German National Academy of Sciences Leopoldina since 2014.